US Stock MarketDetailed Quotes

Karyopharm Therapeutics (KPTI)

Watchlist
  • 8.660
  • -0.090-1.03%
Close Apr 24 15:59 ET
  • 8.660
  • 0.0000.00%
Post 16:10 ET
195.23MMarket Cap-0.48P/E (TTM)

Karyopharm Therapeutics (KPTI) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-41.36%63.74M
-41.36%63.74M
-65.64%45.88M
-66.02%51.7M
-52.93%69.94M
-43.21%108.71M
-43.21%108.71M
-35.90%133.53M
-35.75%152.12M
-42.94%148.58M
-Cash and cash equivalents
-3.10%60.54M
-3.10%60.54M
-48.27%37.67M
-54.32%38.73M
26.63%38.78M
19.61%62.48M
19.61%62.48M
66.83%72.83M
4.80%84.77M
-63.56%30.63M
-Short-term investments
-93.07%3.2M
-93.07%3.2M
-86.48%8.21M
-80.74%12.97M
-73.58%31.16M
-66.79%46.24M
-66.79%46.24M
-63.14%60.7M
-56.79%67.35M
-33.11%117.95M
Receivables
-14.91%26.18M
-14.91%26.18M
0.31%31.88M
-13.33%32.93M
13.39%35.24M
14.11%30.77M
14.11%30.77M
-16.20%31.78M
17.70%38M
-11.70%31.08M
-Accounts receivable
-14.91%26.18M
-14.91%26.18M
0.31%31.88M
-13.33%32.93M
13.39%35.24M
14.11%30.77M
14.11%30.77M
-16.20%31.78M
17.70%38M
-11.70%31.08M
Inventory
-14.79%4.04M
-14.79%4.04M
-15.11%3.97M
43.61%4.99M
72.23%4.77M
55.73%4.74M
55.73%4.74M
50.47%4.67M
-5.34%3.48M
-27.65%2.77M
Restricted cash
----
----
----
----
----
-95.45%30K
-95.45%30K
-93.94%33K
-94.36%32K
-45.74%459K
Other current assets
-24.98%9.19M
-24.98%9.19M
-45.57%8.03M
-44.69%8.25M
-33.55%10.29M
3.66%12.25M
3.66%12.25M
10.59%14.75M
-17.59%14.91M
-15.35%15.48M
Total current assets
-34.08%103.15M
-34.08%103.15M
-51.42%89.75M
-53.07%97.87M
-39.39%120.24M
-33.11%156.46M
-33.11%156.46M
-29.81%184.76M
-28.43%208.54M
-37.73%198.37M
Non current assets
Net PPE
-25.97%4.65M
-25.97%4.65M
55.86%4.8M
40.17%5.33M
30.20%5.8M
28.72%6.28M
28.72%6.28M
-43.80%3.08M
-37.33%3.8M
-32.77%4.45M
-Gross PPE
-21.68%10.16M
-21.68%10.16M
55.86%4.8M
40.17%5.33M
30.20%5.8M
13.35%12.98M
13.35%12.98M
-43.80%3.08M
-37.33%3.8M
-32.77%4.45M
-Accumulated depreciation
17.65%-5.51M
17.65%-5.51M
----
----
----
-1.92%-6.69M
-1.92%-6.69M
----
----
----
Other non current assets
-63.04%618K
-63.04%618K
2.68%1.68M
2.81%1.68M
2.20%1.67M
2.26%1.67M
2.26%1.67M
30.57%1.64M
323.26%1.64M
158.36%1.64M
Total non current assets
-33.76%5.27M
-33.76%5.27M
37.39%6.49M
28.91%7.01M
22.67%7.47M
22.08%7.96M
22.08%7.96M
-29.93%4.72M
-15.69%5.44M
-16.08%6.09M
Total assets
-34.06%108.42M
-34.06%108.42M
-49.21%96.23M
-50.99%104.88M
-37.54%127.71M
-31.62%164.42M
-31.62%164.42M
-29.81%189.48M
-28.15%213.98M
-37.24%204.46M
Liabilities
Current liabilities
Payables
-21.62%4M
-21.62%4M
-6.76%5.39M
-7.15%2.6M
16.79%5.87M
63.53%5.11M
63.53%5.11M
513.26%5.78M
22.30%2.8M
-44.41%5.03M
-accounts payable
-21.62%4M
-21.62%4M
-6.76%5.39M
-7.15%2.6M
16.79%5.87M
63.53%5.11M
63.53%5.11M
513.26%5.78M
22.30%2.8M
-44.41%5.03M
Current accrued expenses
28.63%60.12M
28.63%60.12M
32.38%66.33M
26.34%62.93M
4.23%57.17M
4.13%46.74M
4.13%46.74M
-10.07%50.11M
-3.86%49.81M
16.62%54.85M
Current debt and capital lease obligation
-11.60%21.98M
-11.60%21.98M
272.74%13.67M
805.98%32.12M
641.20%25.39M
651.63%24.86M
651.63%24.86M
14.80%3.67M
14.95%3.55M
15.05%3.43M
-Current debt
-13.99%21.01M
-13.99%21.01M
--12.75M
--30.73M
--24.46M
--24.43M
--24.43M
----
----
----
-Current capital lease obligation
121.23%969K
121.23%969K
-74.86%922K
-60.99%1.38M
-72.93%927K
-86.76%438K
-86.76%438K
14.80%3.67M
14.95%3.55M
15.05%3.43M
Other current liabilities
-3.72%1.58M
-3.72%1.58M
-8.88%1.77M
7.15%1.57M
-4.76%1.94M
-0.79%1.64M
-0.79%1.64M
-13.06%1.94M
-16.07%1.47M
-18.55%2.04M
Current liabilities
-0.22%92.06M
-0.22%92.06M
41.73%87.16M
72.19%99.22M
38.31%90.37M
32.79%92.26M
32.79%92.26M
-0.94%61.49M
-2.22%57.62M
6.15%65.34M
Non current liabilities
Long term debt and capital lease obligation
24.74%211.63M
24.74%211.63M
-4.11%182.75M
-17.48%158.5M
-6.76%161.32M
-2.33%169.66M
-2.33%169.66M
9.30%190.59M
9.77%192.09M
-1.48%173.01M
-Long term debt
26.35%205.89M
26.35%205.89M
-7.27%176.74M
-20.34%152.25M
-9.52%154.83M
-4.66%162.95M
-4.66%162.95M
11.65%190.59M
12.10%191.13M
0.48%171.13M
-Long term capital lease obligation
-14.44%5.74M
-14.44%5.74M
--6.01M
554.55%6.25M
244.21%6.49M
140.66%6.71M
140.66%6.71M
--0
-78.78%955K
-64.52%1.88M
Non current deferred liabilities
-1.58%72.34M
-1.58%72.34M
0.00%73.5M
0.00%73.5M
-44.52%73.5M
-44.52%73.5M
-44.52%73.5M
-44.52%73.5M
-44.62%73.5M
-0.18%132.48M
Derivative product liabilities
13.03%14.22M
13.03%14.22M
-54.11%7.97M
-76.74%4.33M
--3.26M
--12.58M
--12.58M
--17.36M
--18.63M
----
Other non current liabilities
356.58%11.1M
356.58%11.1M
128.30%14.12M
92.85%8.26M
99.30%5.15M
148.47%2.43M
148.47%2.43M
333.05%6.18M
75.81%4.28M
137.97%2.58M
Total non current liabilities
19.80%309.28M
19.80%309.28M
-3.23%278.33M
-15.22%244.59M
-21.05%243.23M
-15.95%258.17M
-15.95%258.17M
-6.70%287.63M
-6.98%288.5M
-0.44%308.07M
Total liabilities
14.53%401.34M
14.53%401.34M
4.69%365.49M
-0.67%343.81M
-10.66%333.6M
-6.96%350.44M
-6.96%350.44M
-5.73%349.12M
-6.22%346.12M
0.66%373.41M
Shareholders'equity
Share capital
7.69%14K
7.69%14K
0.00%13K
0.00%13K
8.33%13K
8.33%13K
8.33%13K
8.33%13K
8.33%13K
0.00%12K
-common stock
7.69%14K
7.69%14K
0.00%13K
0.00%13K
8.33%13K
8.33%13K
8.33%13K
8.33%13K
8.33%13K
0.00%12K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-12.54%-1.76B
-12.54%-1.76B
-8.13%-1.66B
-8.23%-1.62B
-4.10%-1.59B
-5.14%-1.56B
-5.14%-1.56B
-6.05%-1.53B
-6.37%-1.5B
-10.62%-1.52B
Paid-in capital
6.44%1.47B
6.44%1.47B
1.10%1.39B
1.20%1.39B
1.87%1.38B
1.98%1.38B
1.98%1.38B
2.06%1.37B
2.15%1.37B
1.70%1.36B
Gains losses not affecting retained earnings
119.94%71K
119.94%71K
-16.67%-259K
58.51%-251K
38.03%-321K
-121.12%-356K
-121.12%-356K
70.08%-222K
22.73%-605K
-23.63%-518K
Total stockholders'equity
-57.47%-292.93M
-57.47%-292.93M
-68.66%-269.26M
-80.81%-238.93M
-21.86%-205.88M
-36.57%-186.02M
-36.57%-186.02M
-59.02%-159.65M
-85.46%-132.14M
-274.01%-168.96M
Total equity
-57.47%-292.93M
-57.47%-292.93M
-68.66%-269.26M
-80.81%-238.93M
-21.86%-205.88M
-36.57%-186.02M
-36.57%-186.02M
-59.02%-159.65M
-85.46%-132.14M
-274.01%-168.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -41.36%63.74M-41.36%63.74M-65.64%45.88M-66.02%51.7M-52.93%69.94M-43.21%108.71M-43.21%108.71M-35.90%133.53M-35.75%152.12M-42.94%148.58M
-Cash and cash equivalents -3.10%60.54M-3.10%60.54M-48.27%37.67M-54.32%38.73M26.63%38.78M19.61%62.48M19.61%62.48M66.83%72.83M4.80%84.77M-63.56%30.63M
-Short-term investments -93.07%3.2M-93.07%3.2M-86.48%8.21M-80.74%12.97M-73.58%31.16M-66.79%46.24M-66.79%46.24M-63.14%60.7M-56.79%67.35M-33.11%117.95M
Receivables -14.91%26.18M-14.91%26.18M0.31%31.88M-13.33%32.93M13.39%35.24M14.11%30.77M14.11%30.77M-16.20%31.78M17.70%38M-11.70%31.08M
-Accounts receivable -14.91%26.18M-14.91%26.18M0.31%31.88M-13.33%32.93M13.39%35.24M14.11%30.77M14.11%30.77M-16.20%31.78M17.70%38M-11.70%31.08M
Inventory -14.79%4.04M-14.79%4.04M-15.11%3.97M43.61%4.99M72.23%4.77M55.73%4.74M55.73%4.74M50.47%4.67M-5.34%3.48M-27.65%2.77M
Restricted cash ---------------------95.45%30K-95.45%30K-93.94%33K-94.36%32K-45.74%459K
Other current assets -24.98%9.19M-24.98%9.19M-45.57%8.03M-44.69%8.25M-33.55%10.29M3.66%12.25M3.66%12.25M10.59%14.75M-17.59%14.91M-15.35%15.48M
Total current assets -34.08%103.15M-34.08%103.15M-51.42%89.75M-53.07%97.87M-39.39%120.24M-33.11%156.46M-33.11%156.46M-29.81%184.76M-28.43%208.54M-37.73%198.37M
Non current assets
Net PPE -25.97%4.65M-25.97%4.65M55.86%4.8M40.17%5.33M30.20%5.8M28.72%6.28M28.72%6.28M-43.80%3.08M-37.33%3.8M-32.77%4.45M
-Gross PPE -21.68%10.16M-21.68%10.16M55.86%4.8M40.17%5.33M30.20%5.8M13.35%12.98M13.35%12.98M-43.80%3.08M-37.33%3.8M-32.77%4.45M
-Accumulated depreciation 17.65%-5.51M17.65%-5.51M-------------1.92%-6.69M-1.92%-6.69M------------
Other non current assets -63.04%618K-63.04%618K2.68%1.68M2.81%1.68M2.20%1.67M2.26%1.67M2.26%1.67M30.57%1.64M323.26%1.64M158.36%1.64M
Total non current assets -33.76%5.27M-33.76%5.27M37.39%6.49M28.91%7.01M22.67%7.47M22.08%7.96M22.08%7.96M-29.93%4.72M-15.69%5.44M-16.08%6.09M
Total assets -34.06%108.42M-34.06%108.42M-49.21%96.23M-50.99%104.88M-37.54%127.71M-31.62%164.42M-31.62%164.42M-29.81%189.48M-28.15%213.98M-37.24%204.46M
Liabilities
Current liabilities
Payables -21.62%4M-21.62%4M-6.76%5.39M-7.15%2.6M16.79%5.87M63.53%5.11M63.53%5.11M513.26%5.78M22.30%2.8M-44.41%5.03M
-accounts payable -21.62%4M-21.62%4M-6.76%5.39M-7.15%2.6M16.79%5.87M63.53%5.11M63.53%5.11M513.26%5.78M22.30%2.8M-44.41%5.03M
Current accrued expenses 28.63%60.12M28.63%60.12M32.38%66.33M26.34%62.93M4.23%57.17M4.13%46.74M4.13%46.74M-10.07%50.11M-3.86%49.81M16.62%54.85M
Current debt and capital lease obligation -11.60%21.98M-11.60%21.98M272.74%13.67M805.98%32.12M641.20%25.39M651.63%24.86M651.63%24.86M14.80%3.67M14.95%3.55M15.05%3.43M
-Current debt -13.99%21.01M-13.99%21.01M--12.75M--30.73M--24.46M--24.43M--24.43M------------
-Current capital lease obligation 121.23%969K121.23%969K-74.86%922K-60.99%1.38M-72.93%927K-86.76%438K-86.76%438K14.80%3.67M14.95%3.55M15.05%3.43M
Other current liabilities -3.72%1.58M-3.72%1.58M-8.88%1.77M7.15%1.57M-4.76%1.94M-0.79%1.64M-0.79%1.64M-13.06%1.94M-16.07%1.47M-18.55%2.04M
Current liabilities -0.22%92.06M-0.22%92.06M41.73%87.16M72.19%99.22M38.31%90.37M32.79%92.26M32.79%92.26M-0.94%61.49M-2.22%57.62M6.15%65.34M
Non current liabilities
Long term debt and capital lease obligation 24.74%211.63M24.74%211.63M-4.11%182.75M-17.48%158.5M-6.76%161.32M-2.33%169.66M-2.33%169.66M9.30%190.59M9.77%192.09M-1.48%173.01M
-Long term debt 26.35%205.89M26.35%205.89M-7.27%176.74M-20.34%152.25M-9.52%154.83M-4.66%162.95M-4.66%162.95M11.65%190.59M12.10%191.13M0.48%171.13M
-Long term capital lease obligation -14.44%5.74M-14.44%5.74M--6.01M554.55%6.25M244.21%6.49M140.66%6.71M140.66%6.71M--0-78.78%955K-64.52%1.88M
Non current deferred liabilities -1.58%72.34M-1.58%72.34M0.00%73.5M0.00%73.5M-44.52%73.5M-44.52%73.5M-44.52%73.5M-44.52%73.5M-44.62%73.5M-0.18%132.48M
Derivative product liabilities 13.03%14.22M13.03%14.22M-54.11%7.97M-76.74%4.33M--3.26M--12.58M--12.58M--17.36M--18.63M----
Other non current liabilities 356.58%11.1M356.58%11.1M128.30%14.12M92.85%8.26M99.30%5.15M148.47%2.43M148.47%2.43M333.05%6.18M75.81%4.28M137.97%2.58M
Total non current liabilities 19.80%309.28M19.80%309.28M-3.23%278.33M-15.22%244.59M-21.05%243.23M-15.95%258.17M-15.95%258.17M-6.70%287.63M-6.98%288.5M-0.44%308.07M
Total liabilities 14.53%401.34M14.53%401.34M4.69%365.49M-0.67%343.81M-10.66%333.6M-6.96%350.44M-6.96%350.44M-5.73%349.12M-6.22%346.12M0.66%373.41M
Shareholders'equity
Share capital 7.69%14K7.69%14K0.00%13K0.00%13K8.33%13K8.33%13K8.33%13K8.33%13K8.33%13K0.00%12K
-common stock 7.69%14K7.69%14K0.00%13K0.00%13K8.33%13K8.33%13K8.33%13K8.33%13K8.33%13K0.00%12K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -12.54%-1.76B-12.54%-1.76B-8.13%-1.66B-8.23%-1.62B-4.10%-1.59B-5.14%-1.56B-5.14%-1.56B-6.05%-1.53B-6.37%-1.5B-10.62%-1.52B
Paid-in capital 6.44%1.47B6.44%1.47B1.10%1.39B1.20%1.39B1.87%1.38B1.98%1.38B1.98%1.38B2.06%1.37B2.15%1.37B1.70%1.36B
Gains losses not affecting retained earnings 119.94%71K119.94%71K-16.67%-259K58.51%-251K38.03%-321K-121.12%-356K-121.12%-356K70.08%-222K22.73%-605K-23.63%-518K
Total stockholders'equity -57.47%-292.93M-57.47%-292.93M-68.66%-269.26M-80.81%-238.93M-21.86%-205.88M-36.57%-186.02M-36.57%-186.02M-59.02%-159.65M-85.46%-132.14M-274.01%-168.96M
Total equity -57.47%-292.93M-57.47%-292.93M-68.66%-269.26M-80.81%-238.93M-21.86%-205.88M-36.57%-186.02M-36.57%-186.02M-59.02%-159.65M-85.46%-132.14M-274.01%-168.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More